A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)

Clinical trial NCT07732400 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07732400
Sponsor: Kriya Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.